Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands. van Esveld L, Cox JM, Kuijper TM, Bosch TM, et al. Ann Rheum Dis 2023 Jul 9:ard-2023-224190. doi: 10.1136/ard-2023-224190.

Read + Share

Amedeo Smart

Independent Medical Education

van Esveld L, Cox JM, Kuijper TM, Bosch TM, et al. Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands. Ann Rheum Dis 2023 Jul 9:ard-2023-224190. doi: 10.1136/ard-2023-224190.
PMID: 37423648